Overview Financials Chart Business Summary Filings Ownership Valuation

← Scroll for more →

Financial Statements — IBEX

Balance Sheet

(in millions USD)

Metric	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q4 2022	Q4 2021
Cash & Equivalents	32.57	15.41	15.46	22.69	15.35	12.98	20.21	62.31	62.72	50.67	49.02	62.03	57.43	48.83	57.84
Accounts Receivable	125.29	129.15	130.51	116.03	117.14	120.04	120.58	106.04	98.37	103.32	104.75	90.11	86.36	--	--
Total Current Assets	179.64	165.43	158.52	152.75	145.62	148.66	159.02	188.53	179.96	171.35	169.49	167.52	158.61	143.28	141.37
Property, Plant & Equipment	40.73	42.80	44.22	36.54	32.56	30.48	32.17	33.20	29.86	31.47	35.95	37.89	41.15	--	--
Goodwill	11.83	11.83	11.83	11.83	11.83	11.83	11.83	11.83	11.83	11.83	11.83	11.83	11.83	--	--
Total Non-current Assets	129.50	131.82	137.27	131.10	127.60	126.07	113.48	117.75	113.95	118.23	128.68	127.97	134.72	146.86	132.91
Total Assets	309.14	297.25	295.80	283.86	273.21	274.73	272.50	306.27	293.90	289.58	298.17	295.48	293.32	--	--
Accounts Payable	23.00	21.47	24.63	25.39	18.69	18.43	19.92	19.80	16.72	17.54	17.93	18.24	18.70	--	--
Short-term Debt	0.88	0.82	0.84	0.85	--	19.86	--	--	--	--	--	--	--	--	--
Total Current Liabilities	85.54	84.80	86.51	84.01	79.94	89.01	110.64	77.77	71.00	70.76	74.23	73.73	73.26	102.37	105.72
Long-term Debt	0.78	0.57	0.59	0.73	0.80	0.74	0.70	0.80	0.87	0.82	0.56	0.58	0.60	--	--
Total Non-current Liabilities	53.37	51.67	54.78	56.22	58.97	61.54	52.92	57.41	57.11	59.51	67.83	65.72	70.10	87.48	87.91
Total Liabilities	138.91	136.46	141.28	140.23	138.91	150.55	163.56	135.18	128.10	130.27	142.06	139.44	143.36	--	--
Retained Earnings	72.07	63.33	50.00	37.78	25.74	16.15	5.68	(3.59)	(11.12)	(20.97)	(31.28)	(37.35)	(44.78)	(87.69)	(110.68)
Total Stockholder Equity	170.23	160.78	154.51	143.63	134.31	124.18	108.94	171.09	165.80	159.31	156.11	156.04	149.96	100.29	80.66

← Scroll for more columns →

Income Statement

(in millions USD) (except per-share rows)

Metric	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023
Total Revenue	164.27	164.41	164.22	151.18	147.14	140.74	140.68	129.72	124.53	126.80	132.63	124.61	124.43
Selling, General & Admin	31.47	27.47	27.56	26.53	29.76	27.06	25.71	26.22	21.68	23.57	24.86	23.04	23.72
Operating Income	9.82	16.16	15.29	13.70	12.26	13.33	11.93	9.09	12.87	11.28	6.95	8.33	8.31
Pretax Income	9.72	15.97	15.10	13.51	11.84	12.96	11.62	9.51	13.24	11.59	7.35	8.81	8.32
Tax Provision	0.97	2.64	2.88	1.47	2.25	2.49	2.35	1.98	3.39	1.28	1.27	1.39	3.81
Net Income	8.75	13.33	12.22	12.04	9.60	10.47	9.27	7.53	9.85	10.31	6.08	7.43	4.51
Basic EPS	--	0.99	0.91	0.90	0.66	0.79	0.61	0.45	0.56	0.59	0.34	0.41	0.25
Diluted EPS	--	0.89	0.83	0.82	0.63	0.73	0.57	0.43	0.55	0.57	0.33	0.39	0.24

← Scroll for more columns →

Cash Flow Statement

(in millions USD)

Metric	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024
Operating Cash Flow	24.82	11.86	6.64	15.67	27.94	8.83	1.14	7.76	17.42	11.43	(1.64)	8.68
Capital Expenditures	3.16	5.27	11.73	7.64	5.16	5.27	4.32	3.63	2.22	1.69	2.89	2.05
Free Cash Flow*	21.66	6.59	(5.09)	8.03	22.78	3.56	(3.18)	4.13	15.20	9.74	(4.53)	6.63
Investing Cash Flow	(3.16)	(5.27)	(11.73)	(7.64)	(5.16)	(5.27)	(4.32)	(3.63)	(2.22)	(1.69)	(2.89)	(2.05)
Financing Cash Flow	(4.47)	(6.66)	(2.15)	(0.65)	(20.23)	(10.93)	(38.90)	(4.60)	(3.15)	(8.06)	(8.55)	(1.97)

← Scroll for more columns →

* Derived from reported values